InVivo Therapeutics

+$0.0102 (+1.33%) Today
+$0.0089 (+1.14%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NVIV and other stocks, options, and ETFs commission-free!

About NVIV

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.

CEO
Richard Toselli
Employees
6
Headquarters
Cambridge, Massachusetts
Founded
2005

NVIV Key Statistics

Market Cap
26.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
797.38K
High Today
$0.795
Low Today
$0.7699
Open Price
$0.7715
Volume
589.10K
52 Week High
$2.00
52 Week Low
$0.4975

NVIV Earnings

-$0.49
-$0.10
$0.30
$0.69
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure